Compositions and methods for detecting a non plus-stranded...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S029000, C435S184000, C435S239000, C424S009100, C424S009200, C424S093100, C424S093600, C424S093700, C424S209100, C424S211100, C424S520000

Reexamination Certificate

active

07846655

ABSTRACT:
The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus.

REFERENCES:
patent: 4244946 (1981-01-01), Rivier et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5134127 (1992-07-01), Stella et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5376645 (1994-12-01), Stella et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5760029 (1998-06-01), Jadhav et al.
patent: 6252043 (2001-06-01), Hession et al.
patent: 6376172 (2002-04-01), Scholl et al.
patent: 6472206 (2002-10-01), Scholl et al.
patent: 6610474 (2003-08-01), Huang
patent: 0 140 308 (1985-05-01), None
patent: WO 2004/101781 (2004-11-01), None
patent: WO 2005/035712 (2005-04-01), None
patent: WO 2006/091610 (2006-08-01), None
Kleina and Grubman, Antiviral Effects of a Thiol Protease Inhibitor on Foot-and-Mouth Disease Virus, 1992, Journal of Virology, vol. 66, No. 12, pp. 7168-7175.
Benbacer et al. (1997) “Interspecies aminopeptidase-Nchimerase reveal species-specific receptor recognition by canine coronavirus, feline infectious peritonitis virus, and transmissible gastroenteritis virus,” J Virol, 71:734-737.
Blondelle et al. (1995) “Soluble combinatorial libraries of organic, peptidomimetic and peptide diversities,” Trends Anal Chem, 14:83-92.
Chaloner-Larsson et al. “Establishment and maintenance of a persistent infection of L132 cells by human coronavirus strain 229E,” (1981) Arch Virol, 69:117-129.
Cole et al., (1985) “The EBV-Hybridoma Technique and Its Application to Human Lung Cancer,” inMonoclonal Antibodies and Cancer Therapy, Alan R. Liss, Inc., pp. 77-96.
Compton et al. (1982) “Coronavirus species specificity: Murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein,” J Virol, 66:7420-7428.
Cote et al. (1983) “Generation of human monoclonal antibodies reactive with cellular antigens,” Proc Natl Acad Sci USA, 80:2026-2030.
de Kruif et al. (1996) “Biosynthetically lipid-modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes,” FEBBS Lett, 399:232-236.
Delmas et al. (1992) “Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV,” Nature, 357:417-420.
Ding et al. (1995) “Synthesis and biological activity of oligosaccharide libraries,” Adv Exp Med Biol, 376:261-269.
Drosten et al. (2003) “Identification of a novel coronavirus in patients with severe acute respiratory syndrome,” N Engl J Med, 348:1967-1976.
Dveksler et al. (1991) “Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV,” J Virol, 65:6881-6891.
Dveksler et al. (1995) “Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain,” J Virol, 69:543-546.
Dveksler et al. (1996) “Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster of human cells susceptible to MHV infection,” J Virol, 70:4142-4145.
Ecker and Crook (1995) “Combinatorial drug discovery: Which methods will produce the greatest value?” Bio/Technology 13:351-360.
Fields and Noble (1990) “Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids,” Intl Peptide Protein Res, 35:161-214.
Fouchier et al. (2003) “Koch's postulates fulfilled for SARS virus,” Nature, 423:240.
Gleaves et al. (1992) “Detection of human cytomegalovirus in clinical specimens by centrifugation culture with a nonhuman cell line,” J Clin Microbiol 30:1045-8.
Gordon et al. (1994) “Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions,” J Med Chem, 37:1385-1401.
Hambor et al. (1988) “Functional consequences of anti-sense RNA-mediated inhibition of CD8 surface expression in a human T cell clone,” J Exp Med, 168:1237-1245.
Holmes and Lai (1996) “Coronaviridae: The Viruses and Their Replication,” inFields Virology, Third Edition, Lippincott-Raven, pp. 1075-1093.
Holmes et al. (2001) “Coronaviruses,” inFields Virology, Fourth Edition, Lippincott Williams & Wilkins, Chapter 36, pp. 1187-1203.
Huse et al. (1989) “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda,” Science, 246:1275-1281.
Karaoglu et al. (1995) “Functional characterization of Ost3p. Loss of the 34-kD subunit of thesaccharomyces cerevisiaeoligosaccharyltransferase results in biased underglycosylation of acceptor substrates,” J Cell Biol, 130:567-577.
Köhler and Milstein (1975) “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, 256:495-497.
Koivunen et al. (1994) “Isolation of a highly specific ligand for the α5β1integrin from a phage display library,” J Cell Biol, 124: 373-380.
Kolb et al. (1997) “Identification of residues critical for the human coronavirus 229E receptor function of human aminopeptidase N,” J Gen Virol, 78:2795-2802.
Kontoyiannis et al. (2003) “Aminopeptidase N inhibitors and SARS,” Lancet, 361:1558.
Kozbor et at (1983) “The production of monoclonal antibodies from human lymphocytes,” Immunol Today, 4:72.
Ksiazek et al. (2003) “A novel coronavirus associated with severe acute respiratory syndrome,” N Engl J Med, 348:1953-1966.
Kuiken et al. (2003) “Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome,” Lancet, 362:263-270.
Liang et al. (1996) “Parallel synthesis and screening of a solid phase carbohydrate library,” Science, 274:1520-1522.
Look et al. (1989) “Human myeloid plasma membrane glycoprotein CD13 (gpl 50) is identical to aminopeptidase N,” J Clin Invest, 83:1299-1307.
Markus-Sekura (1988) “Techniques for using antisense oligodeoxyribonucleotides to study gene expression,” Anal Biochem, 172:289-295.
Marra et al. (2003) “The genome sequence of the SARS-associated coronavirus,” Science, 300:1399-1404.
Meienhofer, (1973) “Peptide synthesis: A review of the solid-phase method,” inHormonal Proteins and Peptides, vol. 11, Chapter 3, Academic Press (title and copyright pages only).
Murphy and Chanock, (2001) “Immunization against viral diseases” inFields Virology, Fourth Edition, Knipe and Howley, Lippincott Williams & Wilkins, Chapter 16, pp. 435-467.
Nakabayashi et al. (1982) “Growth of human hepatoma cell lines with differentiated function in chemically defined medium,” Cancer Res, 42: 3858-3863.
Nakabayashi el al. (1984) “Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium,” Gann, 75: 151-158 (abstract only).
Nakabayashi et al. (1985) “Hormonal control of α-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium,” Cancer Res. 45:6379-6383.
Palache et al. (1997) “Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs,” J Infect Dis, 176(Suppl 1):S20-S23.
Peiris et al. (2003) “Coronavirus as a possible cause of severe acute respiratory syndrome,” Lancet, 361:1319-1325.
Poon et al. (2003) “Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS),” Clin Chem, 49:953-955.
Poutanen et al. (2003) “Identificatio

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for detecting a non plus-stranded... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for detecting a non plus-stranded..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for detecting a non plus-stranded... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4223544

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.